Physician profile
Donna Corvette
NPI 1316911456
$626.82
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $20.45 · 2021: $48.75 · 2022: $43.13 · 2023: $119 · 2024: $58.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $137.75 | 2019-2024 | Ilumya, Absorica Ld, Winlevi |
| Allergan, INC. | $121.24 | 2019 | |
| Lilly USA, LLC | $90.70 | 2019 | |
| Janssen Biotech, INC. | $37.85 | 2021-2022 | |
| Pfizer INC. | $36.40 | 2019-2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.14 | 2024 | Cabtreo |
| Incyte Corporation | $22.01 | 2022 | |
| Genentech USA, INC. | $21.74 | 2019 | |
| Genzyme Corporation | $20.45 | 2020 | |
| Arcutis Biotherapeutics, INC. | $20.40 | 2023 | |
| Prugen, INC. Pharmaceuticals | $19.21 | 2019 | |
| Abbvie INC. | $16.35 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.27 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $15.75 | 2021 | |
| Biofrontera INC. | $15.67 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $12.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Corvette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.